The global platelet rich plasma (PRP) market size was estimated at USD 474.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.2% from 2022 to 2028. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market’s growth are Some of the key determinants driving the platelet rich plasma market globally are an increase in the number of orthopaedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet rich plasma market’s growth.